Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Blood|May 26, 2010
PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cellsRavikumar Muthuswamy, Jan Mueller-Berghaus, Uwe Haberkorn, et al.
Nature Protocols|January 19, 2018
Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agentsNataša Obermajer, Julie Urban, Eva Wieckowski, et al.
Annals of Surgical Oncology|January 5, 2021
Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal MetastasesRajesh Ramanathan, Haroon Choudry, Heather Jones, et al.
Molecular Cancer|October 11, 2022
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathwaysZhi Zhu, A J Robert McGray, Weijian Jiang, et al.
Journal of Personalized Medicine|December 24, 2021
Tumor Inflammation, Obesity, and Proliferative Status as Biomarkers in Gastroesophageal AdenocarcinomaSarbajit Mukherjee, R J Seager, Yong Hee Lee, et al.
Journal of Immunological Methods|May 2, 2002
A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cellsYoung-Ik Son, Shin-ichi Egawa, Tomohide Tatsumi, et al.
CA: a Cancer Journal for Clinicians|May 12, 2012
Immunotherapy of cancer in 2012John M Kirkwood, Lisa H Butterfield, Ahmad A Tarhini, et al.
Cancers|November 17, 2020
Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)Masanori Oshi, Stephanie Newman, Yoshihisa Tokumaru, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccinationAhmad A Tarhini, Lisa H Butterfield, Yongli Shuai, et al.
Cancer Immunology, Immunotherapy : CII|April 25, 2012
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferationFeng Qian, Jianqun Liao, Jeannine Villella, et al.
Pageof 15